Gland Pharma Limited — Others, 03-07-2025: Options to purchase securities

Gland Pharma has announced a board meeting approving the grant of 15,347 stock options under its ESOP 2025 scheme to one employee. Of these, 10,129 options are priced at INR 937.20 (50% of the closing equity share price on the grant date) and 5,218 options at INR 1 (face value). The options vest over three years—34% after one year, and 33% each after the second and third years—with a two-year exercise period post-vesting. The ESOP will be managed by the company's ESOP Compensation Committee.